drugset / Trial / NCT00111904
Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
Open-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well paclitaxel works in treating patients with unresectable locally advanced or metastatic pancreatic cancer.
Timeline
- Start
- 2005-05
- Primary completion
- 2007-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 300 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 350 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 435 mg/m2 | Intravenous |